Snapshot

DOI:

EuroIntervention: focussing on clinical practice through the latest data and techniques such as managing pulmonary embolisms, antithrombotic monotherapy, CAS- and CEA-related outcomes and more

There is always a lot going on in our field – and just keeping up with the latest research can sometimes seem like a full-time job. We are here to help, and that’s why we often provide you with state-of-the-art and expert reviews as well as touching on a vast range of topics, for instance, in this issue, from outcomes in carotid artery interventions to an interesting approach to using crushed prasugrel in STEMI patients and much more. Read on, and I am sure you will find something of interest!

Percutaneous treatment of pulmonary embolism

Simone Finocchiaro, Davide Capodanno and colleagues offer a state-of-the-art review of emerging percutaneous interventional procedures for pulmonary embolism, including catheter-directed thrombolysis and mechanical thrombectomy, providing guidance on the selection of patients and the appropriate treatments.

See page e408

Efficacy of antithrombotic monotherapy according to revascularisation

Takashi Noda, Satoshi Yasuda and colleagues demonstrate that rivaroxaban monotherapy had favourable safety and efficacy outcomes over combination therapy in high thrombotic risk patients with a history of prior revascularisation in this post hoc analysis of the AFIRE trial.

See page e425

Crushed prasugrel loading dose in STEMI patients

Jeroen M. Wilschut, Roberto Diletti and colleagues investigate if patients with a large myocardial infarction benefit from prehospital administration of a crushed prasugrel loading dose. Improvements in postprocedural TIMI 3 flow after receiving the crushed loading dose led the authors to believe this may be a rapid and cost- effective strategy to improve myocardial perfusion.

See page e436

Comparison of carotid artery stenting- and carotid endarterectomy-related outcomes

Alberto Bramucci, Fausto Castriota and colleagues compare carotid endarterectomy and carotid artery stenting for the treatment of extracranial carotid artery stenosis. Carotid artery stenting has developed on both the surgical and endovascular fronts, and the authors find the 30-day outcomes for stroke, acute myocardial infarction, and death to be similar for both carotid artery stenting and carotid endarterectomy.

See page e445

Volume 20 Number 7
Apr 1, 2024
Volume 20 Number 7
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00052 Jan 19, 2026
Residual postprocedural gradients after transcatheter aortic valve implantation: a small number with a big impact?
Rheude T and Alvarez Covarrubias H
free

Editorial

10.4244/EIJ-E-25-00054 Jan 19, 2026
Randomised trials in mitral transcatheter edge-to-edge repair: taking yet another look
Besler C and Westermann D
free

Original Research

10.4244/EIJ-D-25-00575 Jan 19, 2026
Predictors of long-term structural valve deterioration and failure after transcatheter aortic valve implantation
Palmerini T et al

Research Correspondence

10.4244/EIJ-D-25-00603 Jan 19, 2026
Atrial fibrillation following patent foramen ovale closure: a cohort study with continuous implantable cardiac monitoring
Gautier P et al
open access

Flashlight

10.4244/EIJ-D-25-00658 Jan 19, 2026
Paraplegia after implantation of a transcatheter aortic valve
Zahn R et al

Letter to the editor

10.4244/EIJ-D-25-00949 Jan 19, 2026
Letter: Beta blocker withdrawal post-MI - the missed dimension of patient symptoms
Shamsulddin A
free

Reply to the letter to the editor

10.4244/EIJ-D-25-01076 Jan 19, 2026
Reply: Beta blocker withdrawal post-MI - the missed dimension of patient symptoms
Rossello X and Ibáñez B
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved